Peter R. Young, Ph.D. has joined Genelabs Technologies as vice president, biology. Dr. Young joins the company from Celera Genomics, where he served as vice president, biology. He reports to Ronald C. Griffith, Ph.D., Genelabs’ chief scientific officer. Prior to Celera, Dr. Young was vice president, research at Sugen, Inc. and previously was director, metabolic disease with DuPont Pharmaceuticals and Bristol Myers Squibb and director, molecular biology with SmithKline Beecham. He is a...